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Abstract
Choriocarcinoma, a trophoblastic neoplasia, occurs in women as an incidence of abnormal pregnancy. BeWo choriocarcinoma 
cells derived from the abnormal placentation are a suitable model system to study the factors associated with differentiation, 
invasion and other cellular events as an alternative to clinical samples. Many protein kinases orchestrate the complex events 
of cell cycle and in case of malignancy such regulators are found to be mutated. In the present study, BeWo cells treated with 
forskolin (Fo) and phorbol 12-myristate 13-acetate (PMA) were used to study the role of PKA (protein kinase A) and PKC 
(protein kinase C), respectively, on the expression pattern of differentiation-related genes, membrane markers, PKC isoforms 
and cell cycle regulators. The effect of Fo and PMA on the cell proliferation was assessed. Progressive induction of alkaline 
phosphatase level and formation of multinucleated differentiated cells were observed in the cells treated with Fo. Exposure 
of cells to Fo and PMA induced the mRNA transcripts of α-hCG, β-hCG and endoglin and down-regulates E-cadherin 
at mRNA and protein levels. Synergistic levels of both up- and down-regulated genes/proteins were observed when cells 
were treated with the combination of Fo and PMA. The mRNA levels of cyclin D1, cyclin E1, p21, Rb, p53, caspase-3 and 
caspase-8 decreased gradually during differentiation. Fo significantly inhibited the protein levels of PCNA, Rb, PKC-α and 
PMA stimulated mRNA expression of PKC-ε and PKC-δ. Further, failure in the activation of essential components of the 
cell cycle machinery caused G2/M phase arrest in differentiating BeWo cells.
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Introduction
Choriocarcinoma, a gestational trophoblastic neoplasia, 
occurs in women as a placental disorder. Gestational troph-
oblastic disease (GTD) develops with failure in common 
regulatory mechanisms of cells which leads to benign hyda-
tidiform mole, malignant choriocarcinoma, invasive mole 
or placental site trophoblastic tumour [1, 2]. GTD causes 
adverse pregnancy outcome including placental abruption, 
preeclampsia, preterm birth and intrauterine growth restric-
tion [3]. Unlike other forms of GTD, choriocarcinoma ini-
tially localized in the uterus and aggressive neoplasm gradu-
ally spreads to the other organs, viz. lung, liver and brain, 
and remain fatal if untreated [4, 5]. Gestational choriocarci-
noma produces high levels of β-hCG (human chorionic gon-
adotropin) even in the absence of embryo. Gestational cho-
riocarcinoma responds to chemotherapy with a cure rate of 
80% [6, 7]. Despite a markedly improved prognosis because 
of chemotherapy, a substantial proportion of patients with 
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choriocarcinoma continue to succumb to the disease. The 
relative rarity of the incidence and clinical background make 
it difficult to obtain sufficient samples for investigation of 
the disease [8]. Hence, choriocarcinoma cell lines derived 
from human spontaneous choriocarcinoma are widely used 
to study molecular mechanisms underlying syncytialization, 
adhesion and migration due to constraint use of in vivo sam-
ples [9].
Trophoblast is considered as a specialized structure hav-
ing the characteristics of an epithelial cell, involved in the 
exchange of gases, nutrients and waste across the mater-
nal–foetal interface [10]. The human trophoblast is charac-
terized by a tightly controlled programme of cell prolifera-
tion, differentiation, invasion, angiogenesis and apoptosis 
[11]. During the initial phase of human trophoblast differen-
tiation, the cytotrophoblast cells fuse to form multinucleated 
syncytiotrophoblasts and largely express human placental 
lactogen, alkaline phosphatase, hCG, endoglin and syncy-
tin following the repression of E-cadherin in differentiated 
cells [12–16]. The formation of syncytium, characterized as 
multiple nuclei sharing one cytoplasm, is the most important 
hallmark of cytotrophoblast differentiation [17, 18]. How-
ever, the mechanism by which villous cytotrophoblast under-
goes intercellular fusion and functional differentiation is not 
clear, although there is unsurpassed evidence that supports 
the involvement of hormones, growth factors, cytokines, 
membrane proteins, protein kinases, intracellular proteases 
and transcription factors [19]. Many protein kinases orches-
trate the complex events of cell cycle and differentiation, but 
in malignancy most of the regulator genes are mutated and 
exhibit altered levels of mRNA and protein expression [20]. 
Such changes contribute to deregulation of cell cycle and 
altered activity of kinases or phosphatases associated with 
epithelial–mesenchymal transition, aberrant cell division 
and proliferation [21]. Different phases of cell division (G1, 
S, G2 and M) function as an intricate system that safeguard 
as cell cycle checkpoints. The phases are mediated mainly by 
cyclins, cyclin-dependent kinases (CDK), Rb, p53 and E2F 
proteins. CDKs are also controlled by the family of CDK 
inhibitory proteins (INK4) and kinase inhibitory proteins 
(KIP) [22, 23].
In placental choriocarcinoma cells, syncytiotrophoblast 
formation is a downstream fusogenic event and the cascade 
is believed to begin with increased cyclic AMP (cAMP) 
levels, which occurs via the activation of adenylyl cyclase 
and the consequent activation of PKA (protein kinase A) 
that resembles the in vivo trophoblast cell differentia-
tion. Forskolin (Fo), an activator of adenylyl cyclase, is 
used to induce the differentiation of in vitro cell models 
[24]. The role of cAMP in cell cycle growth and cancer 
development is well established with various cancer cell 
types [25]. The effects of gonadotropins on ovarian cell 
proliferation and differentiation are mediated by changes 
in intracellular cAMP that activates PKA [26]. Hormonal 
cAMP regulation of ERK cascade provides an important 
crosstalk between hormones and growth factor signaling 
[27]. The cAMP appears to act as both an activator as well 
as an inhibitor of cell proliferation [28] and effects the 
production of a variety of proteins including hormones, 
enzymes, cellular oncogenes and extracellular matrix pro-
teins. Researchers from various laboratories reported that 
cAMP inhibits the cell growth of adipocytes [29], endothe-
lial cells [30], NIH 3T3 cells [31] and hepatocytes [32] by 
blocking the activation of ERKs and cascades. The cAMP 
is also shown to activate multiple intracellular signalling 
cascades independent of its activation of PKA [28]; how-
ever, most of the studies examining cAMP inhibition of 
ERKs show the requirement for PKA [29–31].
Protein kinase C (PKC), a superfamily of serine/threo-
nine kinases and its isoenzymes, has been shown to dis-
play variable expression profiles during cancer progression. 
PKC isoenzymes are classified into conventional (α, β and 
γ), novel (δ, ε, η and θ) and typical (µ, ξ and τ) forms based 
on the differences in their N-terminal regulatory domain 
[33]. PKCs have been traditionally viewed as lipid-sensitive 
enzymes activated by growth factor and its receptors. PKCs 
are pharmacologically activated by phorbol esters such as 
phorbol 12-myristate 13-acetate (PMA), which anchors PKC 
in their active conformation. Thus, the activation of different 
types of PKCs depends on the different cellular responses 
and cross-talks between PKC isoenzymes are specific for 
particular cell types [34]. PMA stimulates the differentia-
tion of leukaemia cells via activation of MAPK kinase/ERK 
signaling pathway [35, 36] and used as an agent in ‘differ-
entiation therapy’, a promising strategy for cancer treatment 
[37]. In intestinal epithelial cells, PKC-α exerts anti-prolifer-
ative action in association with ERK activation by inhibiting 
p21 and p27 during the G1 phase of cell cycle [38]. PKC-δ 
down-regulates the expression of cyclins causing G1 and 
G2 phase of cell cycle arrest in lung adenocarcinoma cells 
[39, 40]. Earlier reports demonstrate the PMA-induced dif-
ferentiation and production of hCG with the involvement 
of signal transduction pathways [41] and the activation of 
both PKA and PKC results in a synergistic increase in the 
transcription of α and β subunits of hCG in choriocarcinoma 
cell lines [42, 43]. Although several reports on the role of 
PKA and PKC in choriocarcinoma are available, the mul-
tiple signal transduction pathways involving different types 
of protein kinases during the differentiation of cytotropho-
blast to syncytiotrophoblast are less understood. Hence, in 
the present study Fo is used to induce the differentiation 
of human choriocarcinoma cells. Further, the role of PKA 
activated by Fo and PKC by PMA on the expression pattern 
of differentiation-related genes/proteins, membrane markers 
and PKC isoforms and their effects on different cell cycle 
regulators in BeWo cells are investigated.
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Materials and methods
Materials
Nutrient mixture F-12 Ham Kaighn’s medium (Ham’s 
F-12K), fetal bovine serum (FBS), penicillin, strepto-
mycin, glutamine, dimethyl sulfoxide (DMSO), trypsin, 
trypan blue, 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl 
tetrazolium bromide (MTT), phenol, DEPC (diethyl 
pyrocarbonate), sodium acetate, chloroform, isopropyl 
alcohol, Tris base, EDTA, glacial acetic acid, formal-
dehyde, Tris–HCl, glycerol and ethidium bromide were 
purchased from HiMedia (Mumbai, India). Bromophenol 
blue, acrylamide and bis-acrylamide were procured from 
Sisco Research Laboratories Pvt. Ltd. (Mumbai, India). 
T-25 and T-75 culture flasks, 6-well and 96-well culture 
plates and PCR tubes were purchased from Tarsons (Ben-
galuru, India). TRIzol reagent, secondary anti-rabbit/
mouse antibodies and oligo forward and reverse primers 
(Table 1) were designed and were purchased from Sigma-
Aldrich (St Louis, USA). Oligo dTs and Superscript III 
First-Strand cDNA Synthesis kit were obtained from Inv-
itrogen BioServices India Pvt. Ltd. (Bengaluru, India). 
Taq DNA polymerase (1 U/µL) and Luminata Forte West-
ern HRP substrate were procured from Merck-Millipore 
(Mumbai, India).
Methods
Culturing of BeWo cells
BeWo cells (human choriocarcinoma cell line was a kind gift 
by Prof. Satish Kumar Guptha, Reproductive Cell Biology 
Laboratory, National Institute of Immunology, New Delhi, 
India and was originally procured from American Type Cul-
ture Collection, VA, USA) were cultured with or without 
Table 1  Sequence of primers 
(F: forward and R: reverse) used 
for the amplification of genes
Columns 3 and 4 show the different annealing temperatures used and the size of the amplified products, 
respectively
Gene Primer sequence (5′ → 3′) Annealing 
temp. (°C)
Product 
size (bp)
α-hCG F: GAG AAA GGA GCG CCA TGG AT
R: ACA AGT ACT GCA GTG GCA CG
61.5 347
β-hCG F: GTT CCA GGG GCT GCT GCT GTT 
R: CGG GAG TCG GGA TGG GCT TGG 
64 457
E-cadherin F: CGC ATT GCC ACA TACA 
R: CGT TAG CCT CGT TCTCA 
56 502
Endoglin F: CGT GGA CTG GTT AGT TGA 
R: AGG CTG TCC ATG TTG AGG CAGT 
55 416
PKCε F: CTT CTC GAC CCC TAC ATT GCC 
R: GCA GGT GCA GAC TTG ACA CTG 
61 449
PKCδ F: CTG CAA GAA GAA CAA TGG CAAG 
R: ATC CAC GTC CTC CAG GAA ATACT 
62 96
p53 F: GAG CCC CCT CTG AGT CAG 
R: GCA AAA ACA TCT TGT TGA G
56 375
Rb F: AAG TAC CCA TCT AGT ACT 
R: AAG TTA CAG CAT CTC TAA A
58 547
p21 F: GAT CAC AAG CAG TGG GGT GA
R: CTG AGT GAC TGC ACG ACC TT
58 160
CDK-4 F: AGT GGC GGA TCC ATG GCT ACC TCT CGA TAT 
R: TCT CGG AAG CTT TCA CTC CGG ATT ACC TTC A
60 912
Cyclin D1 F: AGA CCT GCG CGC CCT CGG TG
R: GTA GTA GGA CAG GAA GTT GTTG 
58 574
Cyclin E1 F: GTC CTG GCT GAA TGT ATA CATGC 
R: CCC TAT TTT GTT CAG ACA ACAT 
60 415
Caspase-8 F: GAT ATT GGG GAA CAA CTG GAC 
R: CAT GTC ATC ATC CAG TTT GCA 
58 366
Caspase-3 F: TTA ATA AAG GTA TCC ATG GAG AAC ACT 
R: TTA GTG ATA AAA ATA GAG TTC TTT TGT GAG 
59 848
β-actin F: TAC CAC TGG CAT CGT GAT GGACT 
R: TCC TTC TGC ATC CTG TCG GCAAT 
62 516
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serum in Ham’s F-12K medium supplemented with 10% 
FBS, penicillin (100 u/mL) and streptomycin (100 u/mL) 
under the atmosphere of 5%  CO2 and 95% air in a humidi-
fied incubator at 37 °C. The 25 cm2 culture flask containing 
80–90% confluent cells were subcultured into a 96-well plate 
(3 × 103 cells/well) or a 6-well plate (3 × 105 cells/well) for 
the experimental studies.
Differentiation of BeWo cells
BeWo cells were cultured in Ham’s F-12K medium sup-
plemented with 10% FBS for 24 h in a  CO2 incubator. For 
induction of differentiation, the cells were serum starved for 
4 h. Further, cells were treated with Fo (50 µM) in serum-
free Ham’s F-12K medium supplemented with 1X ITS solu-
tion containing final concentrations of insulin (10 µg/mL), 
transferrin (5.5 µg/mL), selenium (0.005 µg/mL) and BSA 
(500 µg⁄mL) for different time periods (24, 48 and 72 h).
Assessment of cell viability
The cell viability assay was carried out using MTT as per 
the protocol described earlier [44] with modifications. BeWo 
cells (3 × 103 cells/well) were cultured in a 96-well plate in 
Ham’s F-12K medium and incubated for 24 h in  CO2 incu-
bator prior to exposure for experimental conditions. At the 
end of experiment 50 µL of MTT solution (2 mg/mL) was 
added to each well and incubated further for 4 h at 37 °C in 
 CO2 incubator. The formazan product formed in cells was 
dissolved using DMSO (100 µL) and the absorbance was 
measured at 540 nm using PerkinElmer Multimode plate 
reader (MA, USA).
Alkaline phosphatase assay
BeWo cells (3 × 105 cells/well) were cultured in a 6-well 
culture plate in Ham’s F-12K medium and incubated for 24 h 
in a  CO2 incubator. Cells were treated with Fo (50 µM) for 
24, 48 and 72 h in serum-free Ham’s F-12K medium sup-
plemented with 1X ITS solution. After each time point, the 
conditioned medium was removed, cells were washed with 
PBS, cell lysate was prepared using lysis buffer [Tris–HCl 
(50 mM, pH 8.0), NaCl (150 mM), Triton X-100 (0.1%) and 
PMSF (100 µM)] and total protein concentration was meas-
ured by Bradford method [45]. Alkaline phosphatase (ALP) 
expressed in the control and treated cells was analysed using 
p-nitrophenylphosphate (p-NPP) according to the method 
described earlier [46] with modifications and the activity 
was expressed per mg protein. The sample containing ALP 
which results in the appearance of yellow colour was meas-
ured spectrophotometrically at 405 nm using a PerkinElmer 
Multimode plate reader (MA, USA).
RNA isolation and RT‑PCR
BeWo cells were treated with Fo (50 µM) for 24, 48 and 72 h 
and in another set of experiments Fo with or without PMA 
(10 nM) was treated for 72 h by keeping appropriate vehicle 
control. After each time point, the conditioned medium was 
removed and total RNA was isolated using TRI Reagent as 
per the manufacturer’s protocol (Sigma-Aldrich). The qual-
ity and concentration of RNA isolated were assessed on 
1% MOPS-formaldehyde gel. Further, RT-PCR analysis 
was carried out as per the protocol described earlier [47]. 
In brief, equal concentrations of total RNA (2 µg) from the 
control and treated samples were reverse transcribed. The 
cDNA obtained was subjected to PCR using forward and 
reverse primers of respective genes (Table 1). Amplified 
PCR products were analysed by agarose gel electrophoresis. 
Relative mRNA levels were quantified using image analysis 
software (ImageJ—https ://image j.nih.gov/ij/).
Western blot analysis
BeWo cells were treated with Fo (50 µM) for 24, 48 and 72 h 
and in another set of experiments Fo with or without PMA 
(10 nM) was treated for 72 h by keeping appropriate vehicle 
control. After each time point, the conditioned medium was 
removed and total protein was isolated using cell lysis buffer. 
Protein concentration was measured by Bradford’s method 
[45] and subjected to western blot analysis as described ear-
lier [48]. Equal concentrations of protein (40 µg/lane) sam-
ples were electrophoresed on SDS-PAGE and transferred 
onto a PVDF membrane. Membrane was blocked for 2 h 
and incubated with primary antibody (1:500 dilutions of 
rabbit anti-β-hCG/ALP/PKC-α/Rb and 1:1000 dilution of 
mouse anti-E-cadherin/PCNA/GAPDH) overnight at 4 °C. 
Further, the membrane was washed using TBST, incubated 
with anti-rabbit/mouse secondary antibody-HRP (1:1000) 
for 2 h and washed 3–4 times. Protein bands were visualized 
using a Luminata Forte Western HRP substrate in a Syn-
gene Gel Documentation system (MD, USA) and quantified 
using image analysis software (ImageJ—https ://image j.nih.
gov/ij/) [β-hCG, ALP and PKC-α antibodies were procured 
from neobiolab (MA, USA) and Rb was procured from Santa 
Cruz Biotech (CA, USA). PCNA and GAPDH antibodies 
are kind gift by Prof. A. J. Rao, Dept. of Biochemistry 
and E-cadherin by Prof. Annapoorni Rangarajan, Dept. of 
MRDG, IISc, Bengaluru].
Cell cycle analysis
BeWo cells were treated with or without Fo and PMA for 
72 h. Flow cytometry analysis was performed as previously 
described [49]. Cells were harvested, washed with PBS and 
fixed in 70% cold ethanol for 1 h. Further, cells were washed 
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with PBS and suspended in RNase solution (200 µg/mL) for 
30 min incubation at 37 °C. The samples were stained with 
propidium iodide (PI) (50 µg/mL) and analyzed using a Bec-
ton Dickinson FACS Accuri 6 plus flow Cytometry system.
Statistical analysis
The experimental data are shown as mean ± standard devia-
tion from three independent experiments. Statistical analyses 
were done by Student’s t test and one-way ANOVA followed 
by Tukey’s post hoc test. Values were considered statistically 
significant at *P < 0.05 and **P < 0.005 compared to con-
trol, #P < 0.05 compared to Fo-treated sample and $P < 0.05 
when compared to PMA-treated sample.
Results
Forskolin decreases the proliferation of BeWo cells 
with increase in time intervals
To study the effect of Fo on cell proliferation, BeWo 
cells were treated with or without Fo and PKA inhibitor. 
Cells treated with 1 and 10 µM Fo showed a maximum 
increase in the proliferation of about 12 and 5%, respec-
tively, at 24 and 48 h. The cell number gradually decreased 
and attained the level of control at 24 h and a signifi-
cant decrease of 10% in the cell number was observed 
at 100 µM at the time point of 48 h. In cells treated for 
72 h, proliferation was decreased in a dose-dependent 
manner and a statistically significant decrease of 30% 
was observed at 100 µM concentration of Fo (Fig. 1a). 
PKA inhibitor alone was found to have no effect on the 
cell growth. However, an increase in the proliferation was 
observed in the cells treated with Fo + PKA inhibitor com-
pared to the cells treated with Fo alone (Fig. 1b).
PMA decreases the proliferation of BeWo cells
To study the effect of PMA on cell growth, BeWo cells 
were treated with different concentrations of PMA. Cell 
proliferation was decreased with increase in the concen-
tration and statistically a significant decrease of 10% at 
10 nM and an almost 20% decrease in cell proliferation 
were observed at higher PMA concentrations (100 nM and 
1 µM) (Fig. 2).
Forskolin induces alkaline phosphatase in BeWo 
cells
To confirm the action of Fo-mediated differentiation in 
BeWo cells, the alkaline phosphatase activity was meas-
ured. In the presence of Fo (50 µM), cellular alkaline phos-
phatase level increased significantly with an increase in the 
time interval compared to control. The cells treated with Fo 
alone induce the ALP level by 18 and 62% at 24 and 48 h, 
respectively. Progressively, the exposure of cells to Fo for 
72 h show time-dependent induction of ALP enzyme level 
(Fig. 3a) and a twofold increase in ALP protein expression 
was also observed at 72 h (Fig. 3b).
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Fig. 1  Effect of Fo on the proliferation of BeWo cells. BeWo cells 
(3 × 103 cells/well) were treated with or without different concentra-
tions of a Fo (1–100 µM) for different time intervals (24, 48 and 72 h) 
and in another group; b cells were treated with Fo alone (50  µM), 
PKA inhibitor (0.1  µM) alone and Fo + PKA inhibitor for 72  h and 
cell growth was measured by MTT assay. Results were expressed as 
% cell viability compared to control (mean ± SD, n = 4). Values are 
significantly different from control at *P < 0.05 as analysed using Stu-
dent’s t test
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Forskolin induces α‑hCG, β‑hCG and endoglin 
and down‑regulates E‑cadherin mRNA expression 
in BeWo cells
To assess the effect of Fo on the differentiation of BeWo 
cells, the mRNA levels of α-hCG, β-hCG, endoglin and 
E-cadherin were analysed by semi-quantitative RT-PCR. 
BeWo cell differentiation is associated with increased syn-
thesis and secretion of hCG. Choriocarcinoma cells show 
increasing amounts of hCG in response to Fo. The cells 
treated with Fo (50 µM) induced α-hCG mRNA expression 
2.1-fold at 24 h and remain almost similar to the 72-h treat-
ment. However, a time-dependent increase in the mRNA 
levels of β-hCG and endoglin was observed and a maximum 
increase of 4.3- and 1.3-fold was observed at 72 h when 
compared to control (Fig. 4a). E-cadherin, a cell adhe-
sion molecule, was down-regulated by 15 and 42% at 24 
and 72 h, respectively, in the fusing cells (Fig. 4a). Further, 
microscopic observations of multinucleated cells confirm 
the differentiation of BeWo cells (Fig. 4b).
Down‑regulation of PKC‑ε and PKC‑δ transcripts 
in differentiating BeWo cells
BeWo cells treated with Fo to confirm its action on the 
mRNA expressions of PKC-ε and δ. Cells treated with Fo 
progressively inhibit the expression of both PKC-ε and δ 
mRNAs. Initially, at the 24-h time point PKC-ε shows mar-
ginal induction and decline in expression at the 72-h time 
point by 60% compared to the 0-h treatment. In contrast, Fo 
down-regulates PKC-δ mRNA levels in a time-dependent 
manner with a maximum decrease of 32% at 72 h (Fig. 5).
Forskolin regulates mRNA expression of cell cycle 
regulators in BeWo cells
To study the effect of Fo on apoptotic and cell cycle regu-
lators in BeWo cells, the mRNA levels were analysed by 
semi-quantitative RT-PCR. Cells treated with Fo for differ-
ent time intervals progressively down-regulates the mRNA 
expressions of CDK-4, p21, p53, Rb and caspase-3 in a 
time-dependent manner. However, cyclin D1, cyclin E1 
and caspase-8 were induced initially at the 24-h time point 
and the increase in treatment time gradually reduced their 
expression compared to the control cells (Fig. 6). Cyclin 
D1 and cyclin E1 mRNA levels were induced by 22 and 
16% at 24 h and 16 and 10% at 48 h, respectively. Fur-
ther, at 72 h, the mRNA levels of cyclin D1 and cyclin E1 
decreased to 12 and 6%, respectively, compared to control. 
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Fig. 2  Effect of PMA on the proliferation of BeWo cells. BeWo cells 
(3 × 103 cells/well) were treated with or without different concen-
trations of PMA (1  nM–1  µM) in a 96-well plate for 72  h and cell 
growth was measured by MTT assay. Results were expressed as % 
cell viability compared to control (mean ± SD, n = 4). Values are sig-
nificantly different from control at *P < 0.05 as analysed using Stu-
dent’s t test
Fig. 3  Effect of forskolin on 
alkaline phosphatase a enzyme 
activity and b protein expres-
sion in BeWo cells. BeWo 
cells (3 × 105 cells/well) were 
treated with or without Fo (50 
µM) for different time intervals 
(24, 48 and 72 h). Results were 
expressed as alkaline phos-
phatase activity/mg protein and 
as relative expression compared 
to control (mean ± SD, n = 3). 
Values are significantly differ-
ent from control at **P < 0.05 
as analysed using one-way 
ANOVA followed by Tukey’s 
post hoc test
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CDK4 mRNA levels were down-regulated by 10, 22 and 
30% at the 24-, 48- and 72-h time points, respectively. The 
major tumour suppressor genes were found to be down-
regulated with an increase in time of exposure to Fo. p21 
and p53 genes were down-regulated time dependently 
almost 10 and 25% at 48 h and showed a more than 50% 
decrease at 72 h. While Rb mRNA expression decreased 
10% up to 48 h and recorded a 60% reduction in its level 
compared to control. Fo induced the mRNA levels of 
caspase-8 by 20% at the 24-h time point and drastically 
inhibited the same at the 48- and 72-h time points by 10 
and 45%, respectively. However, caspase-3 clearly showed 
15, 40 and 65% time-dependent inhibition of mRNA levels 
with the 24-, 48- and 72-h treatments, respectively.
Fig. 4  Effect of Forskolin on 
a the expression of α-hCG, 
β-hCG, endoglin and E-cad-
herin and b the morphology 
of differentiating BeWo cells. 
BeWo cells (3 × 105 cells/well) 
were treated with Fo (50 µM) 
for different time intervals. The 
expressions of amplified genes 
were analysed on 1% agarose 
gel and β-actin was used as a 
positive control and for normali-
zation. The bar graph represents 
the densitometric analysis of 
mRNA levels (mean ± SD, 
n = 3). Differences in mRNA 
levels are statistically significant 
at *P < 0.05 compared with 
0-h values as analysed using 
one-way ANOVA followed by 
Tukey’s post hoc test
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Fig. 5  Effect of forskolin on the expression of PKC-ε and PKC-δ 
in BeWo cells. BeWo cells (3 × 105 cells/well) were treated with Fo 
(50  µM) for different time intervals. The expressions of amplified 
genes were analysed on 1% agarose gel and β-actin was used as a pos-
itive control and for normalization. The bar graph represents the den-
sitometric analysis of mRNA levels (mean ± SD, n = 3). Differences 
in mRNA levels are statistically significant if *P < 0.05 compared 
with the 0-h values as analysed using one-way ANOVA followed by 
Tukey’s post hoc test
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Forskolin and PMA synergistically induce the hCG 
mRNA levels and down‑regulates E‑cadherin 
mRNA expression; and PMA induces and Fo inhibits 
the mRNA expression of PKC‑ε and PKC‑δ in BeWo 
cells
To study the combinatorial effect of Fo and PMA on BeWo 
cells, cells were treated with Fo alone, PMA alone and 
Fo + PMA for 72 h and the mRNA levels of α-hCG, β-hCG, 
endoglin, E-cadherin, PKC-ε and PKC-δ are analysed by RT-
PCR. The cells treated with Fo alone and PMA alone showed 
an increase in the expression of the mRNA levels of α-hCG 
and β-hCG and down-regulated E-cadherin mRNA expression 
compared to control. However, cells treated with Fo + PMA 
synergistically induced the expression of both α-hCG and 
β-hCG and reduced E-cadherin expression compared to the 
Fo- and PMA-alone treatment (Fig. 7a).PKC-ε and PKC-δ 
show induced mRNA expression only in PMA treatment and 
Fo significantly decreases the above mRNA transcripts com-
pared to control (Fig. 7b).
Regulation of cell cycle regulator transcripts by Fo 
and PMA in BeWo cells
To study the individual and combinatory action of PKA 
and PKC on mRNA expressions of apoptotic and cell cycle 
regulators in BeWo cells, Fo and PMA alone and in com-
bination were treated for 72 h and the mRNA levels were 
analysed by RT-PCR. Cells treated with Fo alone decreased 
the cyclin D1 mRNA by 40% and the cells treated with PMA 
alone showed a marginal increase in cyclin D1. And the 
cells treated with Fo + PMA down-regulated the cyclin D1 
mRNA level by more than 35% when compared to control 
and the expression was similar to the Fo-treated sample. 
However, the CDK-4 level recorded a 10% decrease in Fo- 
and PMA-alone treatments and the combination treatment 
showed 20% inhibition of CDK-4 mRNA expression com-
pared to control. The expression of tumour suppressor genes 
studied here exhibited decreased expression in all the three 
treatments, in which Fo and PMA alone inhibit p21 expres-
sion by 33 and 38%, respectively, and with the combination 
Fig. 6  Effect of forskolin on the 
mRNA expression of apoptotic 
and cell cycle regulators in 
BeWo cells. BeWo cells (3 × 105 
cells/well) were treated with 
Fo (50 µM) for different time 
intervals. The expressions of 
amplified genes were analysed 
on 1% agarose gel and β-actin 
was used as a positive control 
and for normalization. The bar 
graph represents the densito-
metric analysis of mRNA levels 
(mean ± SD, n = 3). Differences 
in mRNA levels are statisti-
cally significant if *P < 0.05 
compared with the 0-h values 
as analysed using one-way 
ANOVA followed by Tukey’s 
post hoc test
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treatment a 55% decrease is observed compared to control. 
Also the level of p53 mRNA was decreased by 38, 15 and 
37%, respectively, in the cells treated with Fo alone, PMA 
alone and Fo + PMA. Further, Fo decreases Rb mRNA levels 
by 53% and Fo + PMA showed only 30% inhibition; how-
ever, a marginal decrease by 10% was observed in the cells 
treated with PMA alone when compared to control. The 
mRNA level of caspase-8 was reduced by 30% in the cells 
treated with Fo alone and PMA alone, and an 18% decrease 
was observed in the cells treated with Fo + PMA when com-
pared to control (Fig. 8).
Fo and PMA regulate protein expressions of β‑hCG, 
PKC‑α, E‑cadherin, PCNA and Rb in BeWo cells
Functional levels of any genes after being transcribed 
into protein are analysed by western blotting. The pro-
tein levels of β-hCG, PKC-α, E-cadherin, PCNA and Rb 
were analysed following the treatment with Fo and PMA 
in BeWo cells. Cells treated with Fo for different time 
intervals showed decreased levels of E-cadherin, PCNA 
and Rb proteins with the increase in time (Fig. 9a). The 
cells treated with Fo + PMA induced the expression of 
β-hCG twofold compared to Fo alone and PMA increased 
β-hCG levels marginally compared to control. However, 
PKC-α decreased marginally in Fo treatment and a signifi-
cant decrease was observed in the cells treated with PMA 
alone and Fo + PMA. Further, E-cadherin and Rb proteins’ 
expressions were down-regulated significantly in the cells 
treated with Fo alone and PMA alone, while in in the cells 
treated with Fo + PMA both proteins are inhibited with 
negligible expressions. The expression of PCNA protein 
was reduced in the cells treated with Fo alone, while there 
was no change observed in the PCNA protein level in the 
cells treated with PMA alone and Fo + PMA (Fig. 9b).
Forskolin and PMA induce G2/M phase cell cycle 
arrest in differentiating BeWo cells
The role of Fo and PMA in regulating cell cycle progres-
sion was studied by flow cytometry. Cells were treated 
with Fo alone, PMA alone and Fo + PMA for 72 h. The 
cells without any treatment were considered as control. 
Results presented in Fig. 10 showed the DNA content of 
control cells with a sharp peak at the G0/G1 phase cor-
responding to 52.3% of cells and a slight peak with 29.2% 
cells at the G2/M phase. Following treatment with Fo and 
PMA, DNA content at the G0/G1 phase decreased to 38.8 
and 40%, while a gradual increase in the DNA content 
of 38.3 and 33.3% at the G2/M phase was observed in 
differentiated cells. Consistent with the syncytial mark-
ers’ expression, the increase in DNA content in the G2/M 
phase (46.8%) and a slight peak with 28.3% at the G0/G1 
phase of cell cycle demonstrate the functional regulation 
of differentiation by Fo and PMA in BeWo cells.
Fig. 7  Effect of forskolin and 
PMA on the mRNA expres-
sion of a α-hCG, β-hCG, 
endoglin, E-cadherin, b PKC-ε 
and PKC-δ in BeWo cells. 
BeWo cells (3 × 105 cells/well) 
were treated with Fo (50 µM), 
PMA (10 nM) and Fo + PMA 
for 72 h. The expressions of 
amplified genes were analysed 
on 1% agarose gel and β-actin 
was used as a positive control 
and for normalization. The bar 
graph represents the densito-
metric analysis of mRNA levels 
(mean ± SD, n = 3). Differences 
in mRNA levels are statisti-
cally significant if *P < 0.05 
compared to control, #P < 0.05 
compared to Fo and $P < 0.05 
compared to PMA as analysed 
using one-way ANOVA fol-
lowed by Tukey’s post hoc test
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Discussion
Cancer is the multi process controlled phenomena and car-
cinoma derived cancers are highly prevalent malignancies 
causing a deadly disease. The survival rates vary dramati-
cally among different type of cancer. Although development 
of targeted therapeutics has been improved in cancer treat-
ment over the years, the harsh reality is that the “War on 
Cancer” still continues [50]. In the present study, human 
BeWo choriocarcinoma cells are used to investigate the 
action of PKA and PKC, the members of protein kinase 
superfamily which are involved in controlling the regulatory 
proteins. These regulatory proteins following the phospho-
rylation activate signal transduction cascades implicated in 
cellular functions and bring down the desired response. Cho-
riocarcinoma cells are derived from the abnormal placenta-
tion and are an appropriate in vitro model system to study 
the factors associated with differentiation, invasion and other 
cellular events as an alternative of clinical samples. Ini-
tially, cell proliferation was monitored by treating the cells 
with different concentrations of Fo and PMA for specific 
time periods. The cells treated with Fo and PMA showed 
a decrease in their proliferation with respect to time and 
concentration which are concurrent with the earlier findings 
[51, 52], where Fo significantly reduced the proliferation of 
BeWo cells in a time-dependent manner and a decrease in 
the proliferation correlates with the growth-restricted pro-
cess of cellular differentiation. In parallel, the PKA inhibitor 
overcomes the Fo effects, which is consistent with the avail-
able reports on PKA activation by Fo in choriocarcinoma 
cells which induces cytotrophoblast cell differentiation into 
syncytiotrophoblast. PMA decreased the cell proliferation 
and suggested a clear indication of the differentiation of cells 
with loss of proliferation as reported in leukaemia HEL and 
K562 cells signifying the role of steady-state maintenance of 
mitochondrial functions in the regulation of differentiation 
by PMA [53]. Further, the results of the expression level and 
enzymatic activity of alkaline phosphatase correlate with the 
progression of Fo-mediated cAMP-induced cell fusion [43].
Morphological changes observed during the treatment 
of cells with Fo clearly reflect the differentiation process. 
In association with the morphological changes, expressions 
Fig. 8  Effect of forskolin and 
PMA on the mRNA expres-
sion of apoptotic and cell cycle 
regulators in BeWo cells. BeWo 
cells (3 × 105 cells/well) were 
treated with Fo (50 µM) and 
PMA (10 nM) and Fo + PMA 
for 72 h. The expressions of 
amplified genes were analysed 
on 1% agarose gel and β-actin 
was used as a positive control 
and for normalization. The bar 
graph represents the densito-
metric analysis of mRNA levels 
(mean ± SD, n = 3). Differences 
in mRNA levels are statisti-
cally significant if *P < 0.05 
compared to control, #P < 0.05 
compared to Fo and $P < 0.05 
compared to PMA as analysed 
using one-way ANOVA fol-
lowed by Tukey’s post hoc test
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of important biochemical markers of differentiation were 
studied. In differentiated cells, the expression of hCG was 
associated with a cAMP-dependent PKA pathway [24, 54] 
and hCG is a glycoprotein that consists of two dissimilar 
subunits, α and β held together by non-covalent interactions. 
Biosynthesis of α subunit which is common to other glyco-
protein hormones and unique subunit β-hCG in pregnant ani-
mal, placental tissue and human choriocarcinoma cell lines 
is extensively validated [54, 55]. In differentiating BeWo 
cells, the mRNA expression of α-hCG was induced early 
by 24 h compared to β-hCG expression which shows a clear 
increase in mRNA transcript over time and induced over a 
period of 72 h suggesting that the production of β-hCG is 
strictly dependent on syncytium formation (fusion of cells) 
[51, 56]. Moreover, silencing of α/β-hCG in choriocarci-
noma cells decreases cell fusion via down-regulation of 
PKA activation establishing the significance of hCG in the 
fusion of BeWo cells [57]. In addition, endoglin, a compo-
nent of TGF-β receptor system, showed a gradual induction 
of its mRNA transcript in Fo-treated BeWo cells. Similarly, 
endoglin expressed in endothelial cells, leukemic cells and 
syncytiotrophoblast is validated as a distinctive differentia-
tion marker [14, 58]. Endoglin is also found to be an active 
regulator of invasive pathway during human trophoblast 
Fig. 9  Effect of forskolin and 
PMA on the E-cadherin, PCNA, 
Rb, β-hCG and PKC-α protein 
levels in BeWo cells. BeWo 
cells (3 × 105 cells/well) were 
treated with Fo (50 µM) for 
different time intervals (24, 48 
and 72 h). In another treatment 
group, cells were treated with 
Fo (50 µM), PMA (10 nM) and 
Fo + PMA for 72 h. GAPDH 
was used as a positive control 
and for normalization. The bar 
graph represents the densito-
metric analysis of protein levels 
(mean ± SD, n = 3). Differences 
in protein levels are statisti-
cally significant if *P < 0.05 
compared to control, #P < 0.05 
compared to Fo and $P < 0.05 
compared to PMA as analysed 
using one-way ANOVA fol-
lowed by Tukey’s post hoc test
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differentiation [59] and in agreement with the statement cad-
herin family of transmembrane glycoprotein E-cadherin, a 
cell adhesion molecule involved in differentiation and inva-
sion, down-regulated its mRNA and protein levels in Fo-
treated cells progressively with an increase in time intervals. 
This is probably due to loss of E-cadherin on the surface of 
fusing cells which is mediated by cAMP in BeWo cells [16].
In some cells, the activation of the cAMP pathway leads 
to the inhibition of receptor-mediated phospholipase C 
(PLC) stimulation. In contrary, stimulation of PLC may 
activate the wide range of PKCs that affect the magnitude 
of cAMP response mediated via other receptors [60]. In our 
report, PMA up-regulates PKC-ε and δ mRNA transcripts, 
whereas Fo alone and in combination with PMA inhibits the 
expression of both isoforms in differentiated cells. However, 
PMA fails to activate and Fo alone and in combination with 
PMA down-regulated PKC-α protein levels. These obser-
vations clearly suggest the involvement of cAMP-mediated 
PLC inhibition in the down-regulation of PKC isoform levels 
in BeWo cells. Omata et al. using BeWo cells demonstrated 
that cell fusion and differentiation are mediated by both 
the PKC and PKA pathways, in which the PKC pathway 
activated by PMA alone can induce major differentiation 
markers and cell fusion as in the case of Fo-PKA-mediated 
syncytia. The syncytium synergistically amplified when both 
protein kinase C and A pathways were activated together 
and suggests that the two parallel pathways may interact at 
multiple levels in the signalling cascade [41, 61]. In compli-
ance with the earlier work, the expression of α- and β-hCG 
levels induced in Fo/PMA-mediated cell differentiation and 
the same mRNA transcripts were synergistically increased 
when the cells are activated together and the β-hCG expres-
sion attains the same status in both mRNA and protein levels 
[42]. Synergistic mRNA and protein levels were observed 
not only in the up-regulated markers but also imply with 
E-cadherin which is down-regulated double the time when 
the cells are treated with Fo or PMA alone and with the 
combination of Fo and PMA.
The most critical step during the transition of cells from 
proliferating to attaining the differentiation stage is the 
inhibition of DNA synthesis [62]. Accordingly, proliferat-
ing cell nuclear antigen (PCNA), an essential component 
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Fig. 10  Effect of forskolin and PMA on cell cycle progression in 
BeWo cells. BeWo cells (3 × 105 cells/well) were treated with Fo 
(50 µM), PMA (10 nM) and Fo + PMA for 72 h. a Flow cytometry 
analysis was performed by PI staining and b results were expressed as 
% of DNA content in different phases of cell cycle
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of the cell cycle machinery that coordinates with cyclins 
to initiate DNA synthesis, showed decreased mRNA and 
protein levels in differentiated BeWo cells [63]. PCNA and 
cyclin expressions are rich in proliferating cancer cells 
and higher levels of PCNA were observed in the inva-
sive hydatidiform mole placentae [64] and overexpression 
of cyclins in cancer cells correlates with the increase in 
malignancy [65]. These findings suggest that the intrinsic 
control could be a crucial factor that prevents the onset 
of malignancy and allows normal pregnancy to ensue. 
Increased expression of cyclins reflects the proliferating 
ability of the cells, whereas lower levels relate to differ-
entiation [12, 23]. Increased cell numbers by Fo at 24-h 
treatment are in agreement with the induced expressions 
of cyclin D1 and cyclin E1 mRNA transcripts and their 
levels decreased over the next 48 and 72 h during which 
syncytialization would be occurring. PMA alone has no 
effect on cyclin D1 and CDK-4 mRNAs but Fo performs a 
similar function even in the presence of PMA [21, 40]. It 
was observed that there was no evidence of CDK-4 induc-
tion and its down-regulation reflects its inactivation status 
preceding syncytialization. Also decreased expressions of 
the CDK inhibitor p21 and the tumour suppressors p53 
and Rb during differentiation appeared to be resistant 
towards apoptosis [66]. The Rb protein expression in Fo 
treatment reduced gradually following syncytia and only 
marginal levels were observed with PMA-treated BeWo 
cells. However, Rb protein levels completely diminished 
in the combinatorial activation of PKA and PKC but not 
with the transcript levels [37].
Syncytialization was associated with the increased lev-
els of the anti-apoptotic and decreased expression of pro-
apoptotic molecules. The present study also shows reduced 
levels of caspase-3 and caspase-8 transcripts in Fo-mediated 
differentiated cells. This is in agreement with the earlier 
results shown by Wei et al. [66]. Moreover, PMA exposure 
also decreased caspase-8 mRNA transcripts and expression 
reflects also in combination with Fo. Altered expressions of 
these transcripts or proteins bring down changes in cellular 
functions and failure in any of the cell cycle events disrupts 
the nuclear content of the cells and it happens even with the 
differentiated cells [62]. Overall DNA content in the G0/
G1 phase reduced with progressive differentiation of cells 
induced by Fo/PMA and simultaneously the G2/M phase 
shows a dramatic increase in DNA content following syn-
cytia in both Fo- and PMA-treated cells. Intensity of nuclear 
content is more in combination and suggests the G2/M phase 
of cell cycle arrest during differentiation. Our study pro-
vides an insight into the regulation of cell cycle players and 
coordinated role of protein kinases as an evidence of BeWo 
choriocarcinoma cell differentiation, and these agents can 
also be used as internal regulators in preventing cancer by 
differentiation therapy approach. Further, the optimization of 
this approach requires an improved understanding of interac-
tions between these classes of agents in cellular functions.
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